Related Experiment Videos
Immunologic evaluation of children with homozygous beta-thalassemia treated with desferrioxamine
C P Speer1, M Gahr, P Schuff-Werner
1Department of Pediatrics, University of Göttingen, FRG.
Insights
Children with thalassemia major undergoing treatment showed normal neutrophil and lymphocyte proliferation. However, some experienced increased T-lymphocyte, helper T-cell, and B-lymphocyte counts, likely due to blood transfusions.
Area of Science:
- Immunology
- Pediatrics
- Hematology
Background:
- Thalassemia major is a severe inherited blood disorder requiring lifelong treatment.
- Standard treatment includes chelation therapy (e.g., desferrioxamine) and regular blood transfusions.
- Immune function in patients with thalassemia major is not fully understood.
Purpose of the Study:
- To comprehensively assess immune functions in children with thalassemia major.
- To investigate phagocyte function, cellular immunity, and humoral defense.
- To correlate immune status with treatment regimens.
Main Methods:
- Analysis of immune functions in 15 children (ages 4-17) with thalassemia major.
- Evaluation of neutrophil functions: adherence, migration, chemotaxis, E. coli killing, superoxide production.
- Assessment of lymphocyte proliferation (phytohemagglutinin, concanavalin A, pokeweed mitogen) and cell counts (T-lymphocytes, helper T-cells, B-lymphocytes).
Main Results:
- Neutrophil functions, including adherence, migration, chemotaxis, and bacterial killing, were normal.
- Lymphocyte proliferation responses to mitogens were comparable between patients and controls.
- Elevated numbers of circulating T-lymphocytes, helper T-cells, and B-lymphocytes were observed in some patients.
Conclusions:
- Children with thalassemia major on desferrioxamine and transfusion therapy exhibit normal neutrophil and lymphocyte proliferation.
- Increased lymphocyte counts may indicate non-specific immune stimulation from frequent blood transfusions.
- Further research is needed to fully elucidate the impact of transfusions on immune status in thalassemia major.
Abstract:
In 15 children with thalassemia major (age 4-17 years) a detailed analysis of different immune functions was performed: phagocyte function, specific cellular immunity, humoral defense system. All patients had been subjected to a desferrioxamine therapy and a high transfusion regimen. Examination of neutrophil function included adherence, random migration, chemotaxis, killing of Escherichi coli and production of superoxide radical; these neutrophil functions were shown to be normal. In addition, lymphocyte proliferation in response to different lectins (phytohemagglutinin, concanavalin A, pokeweed mitogen) was identical in patients and controls. However, the number of circulating T-lymphocytes, helper T-cells and B-lymphocytes was increased in some patients. This phenomenon probably reflects an unspecific stimulation of the antibody-producing cells by repeated blood transfusions.